MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,785,000 | -91.6% | 95,936 | -93.6% | 0.01% | -91.9% |
| Q1 2016 | $69,205,000 | -55.6% | 1,505,118 | -53.3% | 0.12% | -54.6% |
| Q4 2015 | $155,955,000 | +48.9% | 3,226,191 | +30.9% | 0.27% | +30.6% |
| Q3 2015 | $104,711,000 | -8.5% | 2,463,789 | +145.8% | 0.21% | -7.9% |
| Q2 2015 | $114,457,000 | +52.0% | 1,002,251 | +71.8% | 0.23% | +32.0% |
| Q1 2015 | $75,283,000 | +282.7% | 583,271 | +195.3% | 0.17% | +319.5% |
| Q4 2014 | $19,674,000 | +14.3% | 197,513 | +13.5% | 0.04% | -12.8% |
| Q3 2014 | $17,209,000 | +564.4% | 174,053 | +418.0% | 0.05% | +571.4% |
| Q2 2014 | $2,590,000 | +46.8% | 33,600 | +22.6% | 0.01% | +40.0% |
| Q1 2014 | $1,764,000 | -32.2% | 27,400 | -32.8% | 0.01% | -37.5% |
| Q4 2013 | $2,601,000 | +8.3% | 40,760 | +1.7% | 0.01% | 0.0% |
| Q3 2013 | $2,401,000 | +21.7% | 40,060 | -0.1% | 0.01% | +14.3% |
| Q2 2013 | $1,973,000 | -26.9% | 40,104 | -24.0% | 0.01% | -41.7% |
| Q4 2012 | $2,700,000 | – | 52,771 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,198,919 | $283,814,000 | 82.63% |
| BB BIOTECH AG | 1,274,706 | $164,526,000 | 4.90% |
| Selkirk Management LLC | 64,300 | $8,299,000 | 4.61% |
| Opus Point Partners Management, LLC | 30,747 | $3,969,000 | 3.33% |
| Arlington Capital Management, Inc. | 28,845 | $3,723,000 | 2.67% |
| Orbimed Advisors | 2,348,900 | $303,173,000 | 2.59% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 70,900 | $9,151,000 | 2.44% |
| HealthCor Management, L.P. | 375,000 | $48,401,000 | 2.31% |
| BENDER ROBERT & ASSOCIATES | 27,084 | $3,496,000 | 2.04% |
| Eventide Asset Management | 208,200 | $26,872,000 | 2.02% |